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        Upon recognition of MHC ligands on thymic 
stroma, TCR           signaling in CD4 CD8  
(double-positive [DP]) thymocytes mediates 
positive selection and the development of CD4 
and CD8            T cells. There is broad support 
for quantitative models in which the strength/
duration of TCR signals determines the fate of 
a DP thymocyte. Accordingly, the strongest 
TCR signals induce negative selection by dele-
tion; intermediate TCR signals promote positive 
selection and maturation to the single-positive 
(SP), CD4 CD8  or CD4 CD8 , stage; 
and weak or no TCR signals result in cell 
death. The quantity of the TCR signal has also 
been proposed to be a primary determinant in 
CD4 and CD8 lineage commitment. Among 
DP thymocytes receiving TCR signals within 
the range for positive selection, those receiving 
stronger/prolonged signals are biased toward the 
CD4 fate, whereas those experiencing weaker/
transient signals adopt the CD8 fate (  1-3  ). A 
provocative and lingering topic in this fi  eld is 
how quantitatively diff  erent TCR signals in DP 
thymocytes are translated intracellularly to specify 
these T cell fates. 
  The Notch signaling pathway is another 
important regulator of cell fate in thymocytes. 
Notch is essential for commitment of lymphoid 
precursors to the T cell lineage. Notch signaling 
is required in double-negative (DN) CD4        CD8         
thymocytes for maturation through the DN1  –
  DN4 stages, where it has been associated with 
such critical functions as TCR      rearrangement, 
pre-TCR signaling, and           /           T lineage com-
mitment (  4-12  ). Notch has also been implicated 
in the subsequent CD4 versus CD8 lineage de-
cision that is initiated in DP thymocytes ( 13  –  15  ). 
Collectively, these data suggest that recurrent/
continuous Notch signaling may be required 
throughout thymocyte development. 
  Nevertheless, several experimental approaches 
have yielded confl  icting results on the role of 
Notch signaling in the late stages of            T cell 
development. Development of SP thymocytes 
is normal in mice defi  cient for individual Notch 
family members (  16  –  19  ). Inhibiting Notch sig-
naling either by conditional deletion of the tran-
scriptional regulator CBF1/Su(H)/Lag-1 (CSL; 
also called RBPJ     ) or expression of a dn form 
of the transcriptional coactivator Mastermind 
(dnMAML), were also reported to have no ef-
fect on CD4/CD8 T cell fate (  7, 20  ). Likewise, 
overexpression of Numb, which is an antago-
nist of Notch, has no obvious eff  ect on devel-
opment (  21  ). 
  In contrast to these negative results, other 
studies imply that Notch does play a role in 
CD4 and CD8 T cell development. When 
pharmacological inhibitors were added to fetal 
thymic organ cultures to block Notch activa-
tion, the authors of two independent studies 
concluded that Notch activity promotes CD8 
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  TCR         signaling is crucial for the maturation of CD4 and CD8 T cells, but the role of the 
Notch signaling pathway in this process is poorly understood. Genes encoding Presenilin 
(PS) 1/2 were deleted to prevent activation of the multiple Notch receptors expressed by 
developing thymocytes. PS1/2 knockout thymocyte precursors ineffi  ciently generate CD4 
T cells, a phenotype that is most pronounced when thymocytes bear a single major histo-
compatibility complex (MHC) class II  –  restricted T cell receptor (TCR). Diminished T cell 
production correlated with evidence of impaired TCR signaling, and could be rescued by 
manipulations that enhance MHC recognition. Although Notch appears to directly regulate 
binary fate decisions in many systems, these fi  ndings suggest a model in which PS-dependent 
Notch signaling infl  uences positive selection and the development of          T cells by modify-
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commitment, the data demonstrate that PS-dependent Notch 
signaling infl  uences            T cell maturation by modifying TCR 
signal strength in DP thymocytes. 
    RESULTS   
  Generation of conditional PS1/2KO mice 
  PS1 and PS2 are expressed by thymocytes (  Fig. 1 C   and 
Fig. S1, available at http://www.jem.org/cgi/content/full/jem
.20070550/DC1).   PS2-null mice have normal lymphocyte 
development (  Fig. 2   and not depicted). Although PS1-null 
mutant mice die near the time of birth, analyses of hemato-
poietic chimeras made with fetal liver of the mutant indicated 
that lymphocyte development was largely normal (unpub-
lished data). To avoid the embryonic lethality associated with 
gene deletion of both   PS1   and   PS2   (  35, 36  ), we targeted 
deletion of a fl  oxed allele of the PS1 gene (  37  ) specifi  cally to 
developing T cells by expressing a Cd4Cre Tg (  38  ) in the 
development (  22, 23  ). Late thymocyte development is also 
altered in several transgenic (Tg) mouse lines expressing 
the constitutively active Notch intracellular domain (NICD) 
(  13  –  15, 24, 25  ). If mice are analyzed before the appearance of 
tumors, development of SP thymocytes is MHC dependent, 
and NICD favors development of the CD8 over the CD4 
lineage. Because NICD redirected some MHC class II  –  specifi  c 
cells to the CD8 lineage, it was proposed that Notch plays a role 
in CD4/CD8 lineage commitment. Consequently, the confl  ict-
ing results obtained from gain- and loss-of-function Notch stud-
ies, along with the potential for redundancy between Notch 
family members and examples of CSL-independent Notch sig-
naling (  26  ), leave open the question of whether endogenous 
Notch functions in CD4 and CD8 T cell development and 
lineage commitment. 
  The evidence that both TCR and Notch play a role in 
the development of SP thymocytes raises the issue of whether 
these two signaling pathways are functionally linked. Studies 
of mature T cells claiming that TCR stimulation promotes 
the cleavage of Notch are relevant (  27  –  29  ). Conversely, there 
is evidence that Notch signaling modulates TCR signaling in 
mature T cells (  29  –  31  ). Another suggestion that Notch and 
TCR signals may be integrated comes from results showing 
that Notch coclusters with the TCR in antigen-stimulated 
thymocytes (  32  ). In early thymocytes, Notch and pre-TCR 
signals are both required to mediate the DN  –  DP transition 
(  4  ), and in DP thymocytes, a NICD Tg enhances the eff  ects 
of TCR stimulation in regulating gene expression (  33  ). In 
contrast, high levels of NICD were interpreted to inhibit 
TCR signals in a study where DP to SP thymocyte develop-
ment was blocked completely (  34  ). Thus, there is evidence 
for TCR signaling regulating Notch activation, Notch activ-
ity regulating TCR signaling, and evidence that these path-
ways are parallel but linked. At the very least, these results 
suggest some level of cross-talk, which could involve several 
distinct mechanisms. 
  To further investigate these issues, we developed a new 
approach for inhibiting endogenous Notch signaling in thy-
mocytes that avoids the problems of embryonic lethality, 
redundancy, and Notch-induced malignancies that plagued 
many of the earlier studies. The best-characterized pathway 
of how Notch signaling regulates gene expression involves 
the conversion of a transcriptional repressor complex to a 
transcriptional activating complex. Upon ligand engagement, 
Notch receptors undergo two proteolytic cleavages, the sec-
ond involving a presenilin (PS)-containing complex with 
     -secretase activity that releases NICD. NICD translocates 
from the membrane to the nucleus, where it binds to CSL, 
displacing corepressors and recruiting coactivators. Because 
PSs are required for the activation of all four mammalian 
forms of Notch, we generated mice with deletions of both 
  Presenilin1   (  PS1  ) and   PS2   genes, the only genes encoding PS 
in the mouse genome. To target Notch inactivation specifi  -
cally to developing T cells, we introduced Cd4Cre to medi-
ate PS gene deletion in a tissue- and stage-specifi  c manner. 
We fi  nd that rather than directing CD4/CD8 T lineage cell 
  Figure 1. Effi  cient deletion of the fl  oxed   PS1   allele by Cd4Cre in 
developing thymocytes. (A) PCR amplifi  cation of PS1 from the ear, tail, 
or thymus discriminates between the undeleted floxed allele (703 bp), 
the deleted allele (533 bp), and the endogenous (WT) PS1 gene (645 bp). 
A representative experiment assaying deletion in homozygous (lanes 2  –  4) or 
heterozygous (lane 5  –  7) PS1-fl  oxed mice is shown. No deletion is seen in 
the absence of Cre (lanes 8  –  10). (B) Conditional   PS1   gene deletion in total 
thymocytes (left) was staged by PCR analysis of sorted thymocytes from 
  PS1   f/f    Cre     mice (right). (C) Western blot analysis for PS1 protein in 
lysates of thymocytes from six individual littermates bearing fl  oxed   PS1  
with or without Cre expression. Lysates from fetal thymus of   PS1       and 
  PS1     /       littermates are included as antisera specifi  city controls. (D) Semi-
quantitative RT-PCR analysis for Hes1 expression performed using total 
RNA isolated from thymocytes of transgenic pLck- NICD, control, or PS1/
2KO mice. Template cDNA was serially diluted as indicated. A reaction 
with no cDNA template added (-) serves as a negative control.     JEM VOL. 204, September 3, 2007 
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by reconstituting irradiated recipients with PS1/2KO BM, 
confi  rming that decreased cellularity is a cell-intrinsic defect of 
PS1/2KO thymocytes (unpublished data). Moreover, thymus 
cellularity is unaff  ected in mice expressing a Cd4Cre Tg alone, 
with no fl  oxed allele (unpublished data). Because NICD is 
constitutively active in the absence of PS, we expressed a 
NICD Tg in PS1/2KO thymocytes. Thymus cellularity is 
restored to control levels by NICD (  Fig. 2 B  ), supporting the 
hypothesis that decreased thymus cellularity in PS1/2KO mice 
is caused by an absence of Notch cleavage. 
  Although thymocyte numbers are reduced, PS defi  ciency 
does not cause a complete block in development, but rather 
alters the distribution of thymocyte subsets, such that the 
proportion of DN to DP thymocytes is increased (  Fig. 2 E  ). 
Because no substantial diff  erences between the wild-type and 
PS2-defi  cient mice were observed (  Fig. 2   and not depicted), 
all subsequent analyses were performed using PS2KO litter-
mates as controls for conditional PS1/2KO mice. 
  The number of Lin  thymocytes is unchanged, whereas 
DP thymocyte number is dramatically reduced (  Fig. 2 D  ), 
suggesting that in the absence of PS, fewer thymocytes 
mature from the DN to the DP stage. A similar phenotype 
was recently observed in mice expressing an inducible 
dnMAML (  12  ), and these in vivo results corroborate the in 
  vitro results of Ciofani et al. (  4  ), who fi  nd that both Notch 
and pre-TCR signals are absolutely required to mediate an 
effi   cient DN  –  DP transition. Thus, we conclude that with 
Cd4Cre-mediated PS gene deletion, thymocytes that lose PS 
before the DN3 stage fail to progress to the DP stage, whereas 
the DPs that are present must have lost PS after       selection 
was initiated. 
PS2-null background. With this conditional deletion, the de-
leted   PS1   gene is detectable only in T lineage cells (  Fig. 1 A  ). 
  A faint band representing the fl  oxed (f  )   PS1   allele was 
detectable in PCR analyses of DNA isolated from thymo-
cytes of mice with   PS1f/f   Cre  and PS1f/ Cre  genotypes 
(  Fig. 1 A  ). To determine the precise timing of   PS1   gene de-
letion, DNA was isolated from sorted lineage-negative (Lin ), 
DP, or TCR    hi   CD4 or CD8 SP thymocytes.   PS1   deletion 
was detectable as early as the DN2 (CD44 CD25 ) stage (  Fig. 
1 B  ), and the fl  oxed   PS1   allele was virtually undetectable 
by the DP stage and in more mature TCR            hi   CD4 and 
CD8 SP thymocytes. PS1 protein was nearly absent in thy-
mocytes of Cd4Cre   PS1f/f   mice (  Fig. 1 C  ). These data in-
dicate that both   PS1   genes and PS1 protein are effi   ciently 
eliminated in thymocytes of PS1/2 conditional KO mice. 
  Because Notch activation requires PS-dependent cleav-
age, deleting PS genes should inhibit all Notch signaling. 
  Expression levels of a Notch target gene,   Hes1  , were analyzed 
by semiquantitative RT-PCR (  Fig. 1 D  ). Compared with 
wild-type, Hes1 was elevated in thymocytes expressing con-
stitutively active Notch1ICD, and decreased in PS1/2KO 
thymocytes, which was an indication that Notch signaling 
was impaired. 
  Decreased thymus cellularity in the absence of PS 
  To assess the impact of PS defi  ciency on thymopoiesis, thy-
mocyte numbers were analyzed. Thymus cellularity is normal 
in mice defi  cient for PS2 (  Fig. 2 A  ), but is reduced in mice 
defi  cient for PS1 (P   0.01).   Thymus cellularity is further 
reduced in mice lacking both PS1 and PS2 (P   0.0001). 
Thymus cellularity is similarly reduced in chimeric mice made 
  Figure 2. Thymus cellularity is decreased in the absence of PSs. (A) Mean thymus cellularity of WT, PS2 KO, PS1 KO, and PS1/2KO mice. (B) Mean 
thymus cellularity of control and PS1/2KO with or without expression of transgenic NotchIC (NICD). (C) Mean thymus cellularity of H-2  b   WT, PS2 KO, PS1 
KO, and PS1/2KO mice bearing transgenic AND TCR on a H-2  b   RAG2     background. (D) Mean number of lineage negative (gray bars) and CD4    CD8     DP 
(black bars) thymocytes isolated from WT, PS2 KO, PS1 KO, and PS1/2KO mice. (E) Total thymocytes isolated from WT, PS2 KO, PS1 KO, and PS1/2KO litter-
mates analyzed by fl  ow cytometry for expression of CD4 and CD8. Error bars represent the SEM.   n      9 – 48  mice.   2118 TCR AND NOTCH SIGNALING IN          T CELL DEVELOPMENT | Laky and Fowlkes
  CD4 thymocytes are generated ineffi  ciently in the absence 
of PS 
  To address the role of PS in positive selection and the devel-
opment of SP thymocytes, we analyzed TCR            hi   thymo-
cytes. Surprisingly, there are proportionately fewer CD4, and 
more CD8, SP thymocytes in PS1/2KO mice, resulting in a 
decreased ratio of TCR            hi   CD4/CD8 thymocytes com-
pared with that of controls (P   0.0001;   Fig. 3 A  ).   This phe-
notype is also evident in 4-d-old pups (unpublished data), 
suggesting that the diff  erences are not caused by accumula-
tion of mature thymocytes. 
  The loss of DP thymocytes associated with PS defi  ciency 
leads to decreased numbers of both CD4 and CD8 SP cells, 
preventing a direct comparison with SP cell numbers in con-
trol animals. To circumvent this problem, we assessed the ef-
fi  ciency of generating SP thymocytes from DP precursors in 
two ways. In one approach, mice were exposed to in vivo 
continuous BrdU labeling (  39, 40  ). The percentage of BrdU  
cells for each subset was determined (  Fig. 3 B  ). If the slope of 
the line representing BrdU uptake over the fi  rst several days 
is used to estimate the rate of DP thymocyte generation, con-
trol animals generated 3.2   10  7   DP cells per day, whereas 
PS1/2KO animals generated only 5.5   10  6   DP cells per day. 
The rate of SP thymocyte generation was similarly estimated, 
revealing that control animals generated 1.4   10  6   and 4.2   
10  5   CD4 and CD8 SP cells per day, respectively, resulting in 
a CD4/CD8 ratio of 3.3:1. In contrast, PS1/2KO mice gen-
erated only 1.8   10  5   and 7.8   10  4   mature CD4 and CD8 
SP cells per day, respectively, resulting in a CD4/CD8 ratio 
of only 2.3:1. Dividing the rate of CD4 generation by the 
rate of DP generation provides an estimate of the rate of con-
version of DP to SP (  39, 40  ). From this calculation, the effi   -
ciency of DP to CD4 SP thymocyte conversion is     4.3% for 
the controls, but drops by 25% to only 3.3% in the absence of 
  Figure 3. CD4 SP thymocytes are ineffi  ciently generated in the ab-
sence of PSs. (A) Representative FACS plots analyzing the expression of 
CD4 and CD8 among the TCR     hi   thymocytes from control and PS1/2KO 
mice. The bar graph shows the mean ratio of TCR     hi   CD4 to CD8 thymo-
cytes, which was calculated from cell counts and fl  ow cytometric analysis 
of individual mice. Error bars represent the SEM.   n      37 – 40  mice. 
(B) Control and PS1/2KO thymocytes were labeled continuously with BrdU, 
as described in the Materials and methods. The kinetics of BrdU incorpo-
ration within the DP (CD4+CD8+) or TCR  hi   CD4 and CD8 SP thymocytes is 
plotted as a percentage of total thymocytes. Closed triangles and dotted 
lines represent control thymocytes. Open circles and solid lines represent 
PS1/2KO thymocytes. The slopes of the lines did not differ signifi  cantly 
between DP or CD8 SP thymocytes from control or KO mice, but were 
signifi  cantly different for control and KO CD4 SP thymocytes (P   0.01). 
(C) Effi  ciency of generating mature CD4 SP (fi  lled bar) or CD8 SP (hatched 
bar) thymocytes in control or PS1/2KO mice provided with continuous 
BrdU was calculated by dividing the rate of mature SP generated per day 
by the rate of immature DP thymocytes generated per day (left). Effi  -
ciency of generating mature CD4 SP (fi  lled bar) or CD8 SP (hatched bar) 
in the steady state was estimated by determining the ratio of mature SP to 
immature DP thymocytes isolated from individual mice (right). Error bars 
represent the SEM.   n     37  –  40 mice. (D) Thymocytes from H-2  b   control 
and PS1/2KO mice bearing AND TCR analyzed for coexpression of CD4 
and CD8 and gated for TCRV 11 hi  . (E) H-2  b   control (closed triangles and 
dashed lines) and PS1/2KO thymocytes (open circles and solid lines) bear-
ing AND TCR labeled with continuous BrdU as described in B. Data points 
for BrdU  CD4 CD8  DP or TCR  hi   CD4 SP cells are shown as a percentage 
of total thymocytes plotted against labeling time. The slopes of the lines 
did not differ signifi  cantly between control and KO DP thymocytes, but 
were signifi  cantly different for control and KO CD4 SP thymocytes (P   
0.0001). (F) Effi  ciency of generating mature CD4 SP cells in H-2  b   control 
and PS1/2KO mice bearing AND TCR provided with continuous BrdU was 
estimated from the ratio of CD4 SP to DP thymocytes, as described in C 
(left). Effi  ciency of generating mature CD4 SP in steady state was esti-
mated from the ratio of CD4 SP to DP thymocytes as described in C (P   
0.0001; right). Error bars represent the SEM.   n      36 – 46  mice.   JEM VOL. 204, September 3, 2007 
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PS1/2 (  Fig. 3 C  ). In contrast, CD8 SP cells appear to be gen-
erated as effi   ciently in PS1/2KO as in control mice, at 1.3 
and 1.4%, respectively. In a second approach, an estimate of 
the rate of conversion was made based on the size of thymo-
cyte subsets in the steady-state thymus by simply dividing the 
number of TCR            hi   SP thymocytes by the number of DP 
thymocytes. Although the absolute values diff  er slightly from 
those determined in the BrdU-labeling experiments, the same 
trends are observed (  Fig. 3 C  ). The effi   ciency of generating 
CD4 SP from DP precursors is lower in PS1/2KO mice than 
in controls (P   0.03), whereas the generation of CD8 SP is 
similar. Thus, by either analysis, CD4 SP thymocytes are in-
effi   ciently generated in the absence of PS in mice with a di-
verse TCR repertoire. 
  Decreased generation of SP T cells in PS1/2KO thymocytes 
expressing TCR         Tg 
  Although impaired CD4 SP generation in PS1/2KO mice is 
a consistent and statistically signifi  cant fi  nding, the decrease is 
fairly subtle. Even so, alterations in cell fates associated with 
changes in TCR signaling can be masked at the population 
level by the selection of a diff  erent TCR repertoire (  41  –  43  ). 
To assess the aff  ect of PS defi  ciency on CD4 development in 
mice bearing a single TCR          , we generated RAG2  PS1/
2KO mice expressing MHC class II  –  restricted AND TCR. 
Similar to mice with the diverse TCR repertoire, thymus 
cellularity was decreased in PS1KO (P   0.009  )   mice and se-
verely reduced in PS1/2KO mice (P   0.0001;   Fig. 2 C  ). 
Although CD4 SP thymocytes are generated extremely well 
in control H-2  b   AND TCR mice, very few TCR  hi   CD4 SP 
cells are generated in PS1/2KO littermates (  Fig. 3 D  ). Con-
tinuous BrdU labeling studies indicated that control AND 
TCR mice generated 2.6   10  7   DP and 6.4   10  6   CD4 SP 
thymocytes per day, respectively, whereas PS1/2KO AND 
TCR transgenic animals generated only 2.9   10  6   DP and 
9.9   10  4   CD4 SP cells per day, respectively (  Fig. 3 E  ). In 
control AND TCR mice, 25% of DP cells are positively 
  selected to become CD4 SP T cells (  Fig. 3 F  ). In PS1/2KO 
AND TCR mice, the effi   ciency of DP to CD4 SP conversion 
drops precipitously to only 3%. The same trend is observed 
when the rate of conversion was calculated based on the 
CD4/CD8 subsets in the steady-state thymus (  Fig. 3 F  ). Similar 
data were obtained with mice expressing a 5CC7 TCR, 
although the defect in generating CD4 SP thymocytes is less 
severe (Fig. S2, available at http://www.jem.org/cgi/content/
full/jem.20070550/DC1). The diff  erence is most likely ex-
plained by the proposal that 5CC7 TCR has a higher avidity 
for selecting ligand than AND TCR (  44  ). These data suggest 
that PS-dependent Notch signaling may be most important 
for positive selection under conditions where selecting ligand 
and/or TCR affi   nity are limiting. 
  In PS1/2KO mice with a diverse TCR repertoire, no 
diff  erences in the effi   ciency of CD8 generation are detected 
(  Fig. 3  ). However, when the effi   ciency of DP to CD8 SP 
conversion for thymocytes bearing a single class I  –  restricted 
TCR           is analyzed, it is revealed that the generation of CD8 
  Figure 4. Abnormally low CD5 expression by DP thymocytes in the 
absence of PSs. (A) Analysis for expression of CD5 on CD4 CD8  DP 
thymocytes isolated from PS1/2KO (left, open histogram), PS1/2KO 
NotchICD (middle, open histogram), and NotchICD (right, open histo-
gram) littermates. Analysis of a control littermate (shaded histogram) 
is overlaid for comparison. (B) Analysis for expression of CD5 on 
CD4 CD8  DP thymocytes in mixed radiation chimeras that were pre-
pared as described in Materials and methods. Histograms representing 
CD5 levels of wild-type B6 CD45.1 -derived DP thymocytes (shaded 
histogram) overlaid with CD45.2 -derived (open histogram) control 
(left) or PS1/2KO (right) DP thymocytes that developed in the same host. 
(C) Analysis for CD5 expression on DP thymocytes isolated from H-2  b  
control (shaded histogram) and PS1/2KO (open histogram) littermates 
bearing AND (left) or F5 (right) TCR. (D) Analysis for expression of CD5 
on DP thymocytes isolated from PS1/2KO littermates, with (dashed line) 
or without (solid line) a CD5 Tg. CD5 expressed on DP thymocytes iso-
lated from a control littermate (shaded histogram) is overlaid for refer-
ence. An estimate of the mean effi  ciency of generating mature CD4 SP 
(fi  lled bar) and CD8 SP (hatched bar) thymocytes in the steady state was 
estimated as in   Fig. 3 C  . Error bars represent the SEM.   n    13 – 16  mice. 
(E) DP thymocytes isolated from CD5 /  (solid line) or CD5 /  (dotted 
line) PS1/2KO littermates and analyzed for expression of CD5. CD5 ex-
pression on CD4 CD8  DP thymocytes isolated from a control CD5 /  
littermate (shaded histogram) is overlaid for reference. An estimate of 
the mean effi  ciency of generating mature CD4 SP (fi  lled bar) and CD8 
SP (hatched bar) thymocytes in the steady state was estimated as in   Fig. 
3 C  . Error bars represent the SEM.   n      15 – 20  mice.   2120 TCR AND NOTCH SIGNALING IN          T CELL DEVELOPMENT | Laky and Fowlkes
  The low levels of CD5 on DP thymocytes and the exac-
erbation of the PS1/2KO phenotype by restoration of CD5 
expression suggested that TCR signaling was defective in the 
absence of PS. Because the magnitude of calcium/calcineurin 
signals plays a crucial role in TCR signaling and positive se-
lection (  46, 47  ), Ca2  mobilization was analyzed in PS1/2KO 
thymocytes in response to TCR stimulation in vitro. Al-
though the calcium ionophore ionomycin elicited equivalent 
responses in control and PS1/2KO thymocytes, the magni-
tude of Ca2  fl  ux was attenuated in PS1/2KO DP thymo-
cytes at every dose of anti-CD3 tested (  Fig. 5 A  ).   
  Although controversial, PS has been implicated to play a 
role in maintaining intracellular Ca2  stores in some systems/
cell types. To the contrary, treatment of control and PS1/
2KO thymocytes with the sarcoendoplasmic reticulum Ca2 -
ATPase inhibitor thapsigargin, in the absence of extracellular 
Ca2 , demonstrates that PS1/2KO DP thymocytes have nor-
mal intracellular Ca2  stores (  Fig. 5 B  ). 
  We considered the possibility that PS1/2KO DP thymo-
cytes fl  ux Ca2  poorly because they are less mature than DP iso-
lated from control littermates. To analyze a more synchronized 
population, we examined DP thymocytes of mice developing in 
the absence of selecting MHC (  Fig. 5 C   and Fig. S1). Because 
both control and PS1/2KO DP thymocytes are developmen-
tally arrested at a comparable stage in the nonselecting back-
ground, levels of TCR expression are equivalent. Nevertheless, 
Ca2  fl  ux is markedly reduced in the PS1/2KO cells, indicating 
that the TCR signaling defect is intrinsic to PS1/2KO thymo-
cytes and that the defect is initiated before positive selection. 
  As controls for the MHC  hosts, wild-type MHC  mice 
were also irradiated and reconstituted with BM from control 
or PS1/2KO mice (  Fig. 5 C  ). As observed with intact mice, 
PS1/2KO DP thymocytes with a diverse TCR repertoire have 
normal levels of TCR expression, but reduced Ca2  fl  ux, in 
response to TCR cross-linking, confi  rming that the signaling 
defect is intrinsic to DP thymocytes. In contrast to mice with 
a diverse TCR repertoire, however, PS1/2KO DP thymo-
cytes express low levels of AND TCR (  Fig. 5 C  ). Because 
TCR up-regulation is a hallmark of positive selection, these 
lower levels of TCR, coupled with the reduced Ca2  response 
and paucity of mature CD4 SP thymocytes, suggest that posi-
tive selection is severely impaired in the absence of PS. 
  Overexpression of NICD leads to increased expression of 
Bcl-2, which confers resistance to apoptosis (  48, 49  ). We as-
sessed cell death to exclude the possibility that the TCR sig-
naling defect in PS1/2KO thymocytes was related to reduced 
cell survival. As assayed by loss of mitochondrial potential or 
by Annexin V staining, there was no diff  erence in the per-
centage of apoptotic cells ex vivo (unpublished data). 
  To determine if the signaling defect was maintained in 
mature thymocytes, the ability of SP thymocytes to fl  ux Ca2  
in response to TCR cross-linking was analyzed (  Fig. 5 D  ). 
CD4 SP thymocytes of control and PS1/2KO mice fl  ux Ca2  
equally well at higher doses of TCR cross-linking; however, 
when lower doses of anti-CD3 were used, the magnitude 
of Ca2  fl  ux was attenuated in CD4 SP PS1/2KO cells. 
lineage cells is also impaired, albeit less so than CD4 lineage 
cells (Fig. S3, available at http://www.jem.org/cgi/content/
full/jem.20070550/DC1). By focusing on the selection of a 
single TCR, either class I or class II restricted, our analyses 
reveal that development of both CD4 and CD8 lineage cells 
can be impaired in the absence of PS. 
  Attenuated TCR signaling in PS1/2KO thymocytes 
  We considered the possibility that defective TCR signaling 
was responsible for the impaired CD4 T cell development in 
PS1/2KO mice. CD5 expression has been correlated with 
TCR signal strength (  45  ). Despite similar levels of TCR, the 
levels of CD5 expressed by DP thymocytes were dramatically 
reduced in PS1/2KO mice compared with control mice (  Fig. 
4 A  ).   CD5 levels were increased in DP cells expressing 
NICD, and CD5 expression by PS1/2KO DP was restored 
to wild-type levels by expression of NICD. In mixed BM 
chimeras, CD5 levels were markedly lower on PS1/2KO-
derived DP thymocytes than on wild-type  –  derived DP cells 
developing in the same host (  Fig. 4 B  ), but were identical for 
control- and wild-type  –  derived DP thymocytes developing 
in the same host (  Fig. 4 B  ), confi  rming that decreased CD5 
expression is a cell autonomous defect of PS1/2KO DP thy-
mocytes. To exclude the possibility that changes in TCR 
repertoire were responsible for the changes in CD5 expres-
sion, we compared CD5 expression on DP thymocytes ex-
pressing a fi  xed TCR          . As with the diverse TCR repertoire, 
the level of CD5 was signifi  cantly reduced on DP thymo-
cytes of class II  –  restricted AND TCR and 5CC7 TCR and 
class I  –  restricted F5 TCR Tg mice (  Fig. 4 C   and   Fig. 6  ) when 
PSs were absent. Collectively, these data suggested that CD5 
expression by DP thymocytes is regulated by PS. 
  It was not clear whether the alterations in CD5 expres-
sion caused or refl  ected the changes in thymic selection ob-
served with PS defi  ciency. Because CD5 is a negative regulator 
of TCR signaling (  41  –  43  ), its decreased expression would be 
expected to enhance TCR signal strength, and perhaps even 
promote negative selection. On the other hand, PS defi  ciency 
could reduce TCR signal strength at the DP stage, which could 
be refl  ected in altered CD5 levels as a consequence. To dis-
tinguish between these possibilities, we examined the impact 
of forced CD5 expression on the PS1/2KO phenotype. If 
Notch controlled CD5 expression, and CD5 modulation was 
directly responsible for abnormal CD4 SP thymocyte devel-
opment in PS1/2KO mice, then restoration of CD5 levels 
should correct this defect. To the contrary, a CD5 Tg in-
creased CD5 expression, but exacerbated the PS1/2KO phe-
notype (  Fig. 4 D   and not depicted). With the CD5 Tg, thymus 
cellularity was further decreased and the generation of both 
CD4 and CD8 SP thymocytes was even more impaired. 
Conversely, removing CD5 entirely from PS1/2KO thymo-
cytes results in increased thymus cellularity and improved gen-
eration of SP thymocytes (  Fig. 4 E   and not depicted). These 
data are consistent with the notion that reduced expression of 
CD5 is a refl  ection of diminished in vivo TCR signal strength 
in PS1/2KO DP thymocytes. JEM VOL. 204, September 3, 2007 
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most prominent when T cells are stimulated with low-dose 
anti-CD3 in the absence of costimulation (  27  ). 
  Responses of PS1/2KO thymocytes to TCR stimulation 
  Control and PS1/2KO DP thymocytes express comparable 
levels of CD69 ex vivo, indicating that TCR signals transduced 
This phenotype was even more pronounced in CD8 SP thy-
mocytes than CD4 SP thymocytes. These data indicate that 
PSs infl  uence TCR signaling in both MHC class I  –   and class 
II  –  restricted T cells when antigen is limiting. These data are 
consistent with the observation that the ability of Notch 
signaling to augment the responsiveness of mature T cells is 
  Figure 5. Calcium fl  ux in response to TCR cross-linking is reduced in PS-defi  cient DP thymocytes. (A) Mean of calcium fl  ux measurements 
in CD4 CD8  DP thymocytes isolated from control (dashed line) and PS1/2KO (solid line) after stimulation with concentrations of anti-CD3 indicated in 
the insets. (B) Calcium fl  uxes of DP thymocytes isolated from control (dashed line) and PS1/2KO (solid line) littermates in Ca-free media after the addition 
of thapsigargin. (C) Analysis for Ca2  fl  uxes in thymocytes generated from BM chimeras made in MHC-defi  cient (left) or MHC-expressing (right) hosts. 
 Calcium  fl  uxes in PS2KO (dashed lines) or PS1/2KO (solid lines) DP thymocytes are compared in either mice with a diverse TCR repertoire (top) or an AND 
TCR (bottom). Histograms beside each calcium trace plot the levels of TCR expression by DP thymocytes derived from control PS2KO (shaded histogram) 
or PS1/2KO (open histogram) BM. (D) Analysis for Ca2  fl  ux as in A by TCR  hi   CD4  or CD8  SP thymocytes isolated from control (dotted line) and PS1/2KO 
(solid line) littermates.     2122 TCR AND NOTCH SIGNALING IN          T CELL DEVELOPMENT | Laky and Fowlkes
DP thymocytes, CD5 levels correlate with increasing amounts 
of selecting MHC (H-2  bb     <   H-2  bk     <   H-2  kk  ). However, 
within each MHC haplotype, PS1/2KO DP cells express less 
CD5 than controls (  Fig. 6 B  ). These in vivo results are analo-
gous to the in vitro Ca2  response, demonstrating that PS1/
2KO DP thymocytes do not respond as well as controls across 
a range of selecting MHCs. 
  Higher affi  nity MHC ligand improves selection of PS1/2KO 
SP thymocytes 
  Although PS1/2KO DP thymocytes are somewhat compro-
mised, they are capable of responding to TCR stimuli as indi-
cated by their ability to up-regulate CD69 and CD5 in vivo, 
and to mobilize Ca2  and induce CD69 in response to anti-
CD3 in vitro. If attenuated TCR signaling in PS1/2KO DP 
cells were responsible for the impaired development of CD4 
and CD8 SP thymocytes, then SP generation should be 
restored with higher affi   nity and/or density of selecting 
MHC ligands. To determine if higher affi   nity TCR  –  MHC 
interactions could improve positive selection of PS1/2KO 
thymocytes, we compared selection of AND TCR  –  bearing 
thymocytes in mice expressing MHC class II E  k  , to those ex-
pressing A  b  . Although both E  k   and A  b   mediate positive selec-
tion of the AND TCR, E  k   is better recognized than A  b  , and 
can even promote some negative selection (  51  –  53  ). Because 
thymus cellularity was similar in PS1/2KO H-2  bb   and H-2  bk   
AND TCR mice, both the number and the effi   ciency of SP 
thymocyte generation could be compared (  Fig. 7  ).   Indeed, 
positive selection of PS1/2KO SP thymocytes is greater by 
H-2  bk   than by H-2  bb   (P   0.01 and 0.03 for CD4 SP and 
CD8 SP, respectively). Similarly, positive selection of PS1/
2KO thymocytes bearing 5CC7 TCR is markedly better on 
H-2  kk   than on H-2  bk   (Fig. S1). Thus, increasing either the 
TCR affi   nity or the density of selecting MHC can compen-
sate for the attenuated TCR signaling that diminishes posi-
tive selection in the absence of PS. 
    DISCUSSION   
  Several studies suggested that Notch infl  uences the CD4/CD8 
lineage decision, favoring the CD8 over the CD4 fate. These 
results fi  t with evidence from many species, indicating that 
Notch signaling directs binary fate decisions. On the other 
hand, attempts to interfere with endogenous Notch have had 
no obvious eff  ect on thymic selection or development of ma-
ture            lineage T cells. Our studies reveal that PS-dependent 
Notch signaling does, in fact, play a role in generating mature 
thymocytes, but rather than directing lineage commitment, 
Notch mediates its eff  ects by modifying TCR signal transduc-
tion. Importantly, these results indicate that TCR and Notch 
signaling pathways are functionally linked in the selection and 
maturation of            T cells. 
  Our approach was to generate mice with conditionally de-
leted P  S   genes as a means of inhibiting all endogenous Notch 
signaling in developing T cells. The generation of CD4 SP 
thymocytes from DP precursors was ineffi   cient in mice with 
a diverse TCR repertoire, and was severely compromised in 
by positive selection in PS1/2KO thymocytes are suffi   cient 
to induce CD69 expression (  Fig. 6 A  ).   This was not surpris-
ing because CD69 is an early activation marker that can be 
induced by low levels of TCR signaling (  50  ). Moreover, 
control and PS1/2KO up-regulate CD69 equally well after 
TCR stimulation (unpublished data). 
  Although the response is muted, PS1/2KO DP thymo-
cytes fl  ux Ca2  in a dose-dependent manner in response to 
anti-CD3, indicating that they do sense diff  erences in TCR 
signal strength in vitro. To determine if this was true in vivo, 
we measured ex vivo CD5 expression on DP thymocytes 
isolated from 5CC7 TCR mice expressing increasing amounts 
of the selecting MHC. Because 5CC7 TCR is selected by 
class II E  k  , but not by class II, of H-2  b   mice, CD5 expression 
was analyzed on DP thymocytes in nonselecting (H-2  bb  ) or se-
lecting (H-2  bk   or H-2  kk  ) mice. CD5 expression is up-regulated 
on DP thymocytes of 5CC7 TCR mice in response to select-
ing versus nonselecting MHC, irrespective of the PS defi  -
ciency (  Fig. 6 C  ). Moreover, for both PS1/2KO and control 
  Figure 6. PS-defi  cient DP thymocytes respond to selecting MHC 
by up-regulating CD5 and CD69. (A) Analysis for CD69 expression on 
CD4 CD8  DP thymocytes isolated from control (shaded histogram) and 
PS1/2KO (open histogram) mice with either a diverse TCR repertoire (left), 
an AND TCR (middle), or a 5CC7 TCR (right) in a selecting MHC back-
ground. CD69 expressed on DP thymocytes isolated from control mice 
bearing 5CC7 TCR on the nonselecting H-2  b   background (dashed line) are 
overlaid for reference (right). (B) Analysis for expression of CD5 on posi-
tive DP thymocytes isolated from control (shaded histogram) and PS1/
2KO (open) mice bearing 5CC7 TCR on the nonselecting H-2  b  , or selecting 
H-2  bk   or H-2  kk   background. (C) Same data as in B, replotted with control 
(left) or PS1/2KO (right) thymocytes of nonselecting H-2  b   (dashed  lines) 
or selecting H-2  bk   (thin line) or H-2  kk   (thick line) background, overlaid 
for  comparison.   JEM VOL. 204, September 3, 2007 
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I  –  restricted TCR, which are both indicators of impaired 
CD8 T cell development. Notably, a diff  erential aff  ect on 
the development of CD4 versus CD8 SP thymocytes is also 
observed in other mice with defi  ciencies in TCR signaling 
(  54  –  57  ). Given that TCR signaling is required for positive 
selection of both CD4 and CD8 T cells, the question arises 
as to why reduced TCR signaling in DP thymocytes has a 
greater impact on the generation of CD4 cells? The diff  er-
ence is most easily explained by a quantitative signaling model 
in which higher TCR signals are required for CD4 than for 
CD8 T cell commitment (  1-3  ), such that selection of CD4 
T cells would be most aff  ected if TCR signaling was attenu-
ated. The fi  nding that higher density or affi   nity MHC ligands 
rescue development of class II  –  restricted CD4 SP thymocytes 
in PS1/2KO mice is also explained by the model, as is the 
observation that selection of thymocytes with 5CC7 TCR is 
less severely impaired than those with AND TCR in PS1/
2KO mice. 
  How might PS aff  ect TCR signaling in DP thymocytes? 
It is well established that PSs are absolutely required for 
Notch activation, and that Notch signaling is important for 
the DN  –  DP transition. The requirement for Notch activa-
tion in DN3 thymocytes is absolute; thymocytes deprived of 
Notch signaling before   selection cannot progress to the DP 
stage (  4, 5, 9, 11, 12  ). DN4 thymocytes also benefi  t from 
Notch ligand engagement en route to becoming DP cells 
(  11  ). The importance of Notch activation at these stages has 
been demonstrated in vitro by culturing precursors either in 
the absence of Notch ligands or in the presence of pharmaco-
logical PS inhibitors, as well as in vivo by conditional gene 
deletion of CSL or Notch1, or induction of dnMAML. We 
now show that this is true also when thymocytes are geneti-
cally deprived of PS. Why Notch signaling is necessary in 
DN3/4 thymocytes is an open question. The diffi   culty lies in 
the paucity of data on direct target genes regulated by Notch 
in thymocytes and in the complex manner in which Notch 
mediates its eff  ects (  58  ). Notch signaling is an intricate, time-
consuming, and context-dependent process that is initiated 
by ligand engagement and PS-mediated Notch cleavage at 
the cell surface, followed by transcriptional activation in the 
nucleus, resulting in changes in gene expression. Often, the 
genes regulated by Notch are themselves transcription fac-
tors, which in turn regulate the expression of other proteins. 
As it takes  1 d for  -selected DN3 thymocytes to diff  eren-
tiate to the DP stage (  59  ), it is doubtful that the full eff  ects of 
a Notch signal initiated in a late DN3/DN4 thymocyte hap-
pen within the same subset in which Notch ligand engage-
ment and PS-mediated cleavage occurs. Thus, it is likely that 
Notch  –  Notch ligand interactions in late DN3/DN4 thymo-
cytes infl  uence the expression of many genes in late DN/
early DP cells, including some that are important for TCR 
signaling and positive selection. 
  Direct target genes of Notch signaling are largely un-
known, and are highly cell lineage  –   and stage-specifi  c. To 
examine the eff  ects of PS defi  ciency on a broad range of 
genes, we performed microarray analyses of RNA isolated 
mice expressing a single MHC class II  –  restricted TCR. De-
fective CD4 T cell development was associated with impaired 
TCR signaling at the DP stage, as indicated by a reduced Ca2  
response to TCR stimulation in vitro and decreased CD5 
up-regulation in response to selecting MHC in vivo. More-
over, the fact that CD5 expression and the generation of CD4 
SP thymocytes could be improved by higher affi   nity or density 
of selecting MHC ligand demonstrated that defective CD4 
development was a consequence of poor positive selection in 
PS1/2KO thymocytes. The number and phenotype of DP 
was corrected by expression of a constitutively active form of 
Notch, indicating that the phenotypes observed in PS1/2KO 
thymocytes were caused by a loss of Notch signaling. Col-
lectively, our fi  ndings suggest that under physiological con-
ditions, PS-dependent Notch signaling infl  uences  positive 
selection and            T cell maturation by potentiating TCR 
signaling in DP thymocytes. 
  Although the adverse eff  ect of PS-defi  ciency on produc-
tion of CD4 SP was obvious, the eff  ect on CD8 SP thymo-
cytes was evident only in mice expressing a single MHC class 
I  –  restricted TCR. Even though CD8 SP generation appeared 
normal with a diverse TCR repertoire, the Ca2  response to 
TCR stimulation of these cells was attenuated and CD5 ex-
pression was reduced in DP thymocytes bearing a MHC class 
  Figure 7. Ineffi  cient generation of CD4 SP thymocytes in PS-
  defi  cient mice is improved by increasing affi  nity of selecting MHC 
  ligand. (A) Thymocytes of PS1/2KO mice bearing AND TCR on a H-2  bb   or  H-2 bk  
background, gated for TCRV    11 hi   and analyzed for expression of CD4 and 
CD8. (B) PS1/2KO mice bearing AND TCR on a H-2  bb   or  H-2 bk   background 
analyzed for mean thymus cellularity (left), mean number of TCRV    11 hi   CD4 
and CD8 SP thymocytes (middle), and the mean ef  fi  ciency of generating 
mature CD4 SP and CD8 SP thymocytes in the steady state (right), calculated 
as in   Fig. 3 C  . Error bars represent the SEM.   n    16 – 26  mice.   2124 TCR AND NOTCH SIGNALING IN          T CELL DEVELOPMENT | Laky and Fowlkes
possibility is diff  erences in the timing of gene deletion. Cd-
4Cre-mediated deletion of the   PS1   gene is detectable in a 
subset of DN2/DN3 thymocytes, and virtually no fl  oxed   PS1   
remains by the DP stage. In contrast, it is not until thymo-
cytes reach the DP stage that detectable levels of dnMAML-
GFP are expressed in mice with Cd4Cre-mediated induction 
of dnMAML (  20  ), and it is not until the DP stage that most 
thymocytes have undergone deletion of the   RBPJ    gene by 
Cd4Cre in the conditional KO mice (Fig. S5, available at 
http://www.jem.org/cgi/content/full/jem.20070550/DC1) 
(  7  ). Although not discussed by the authors, mice with earlier 
deletion of CSL or expression of dnMAML appear to have 
alterations in SP thymocyte development (  7, 12  ). Because 
both the CSL- and PS-defi  cient mice examined here were 
on mixed genetic backgrounds, it is unclear whether diff  er-
ences in the timing of gene deletion refl  ect diff  erences in ge-
netics and/or accessibility of the targeted loci. Taken with 
the fact that thymocytes deprived of Notch signaling before 
or during      -selection cannot mature past the DN3 stage, 
these data illustrate that the precise timing of Notch inhibi-
tion is a critical factor for revealing adverse eff  ects on SP thy-
mocyte development. 
  Although delayed loss of the   RBPJ    gene may be the most 
likely explanation for why PS1/2KO mice have more severe 
phenotype than   RBPJ        KO mice, it is notable that the dispar-
ities in the phenotype of CSL and PS mutant mice are remi-
niscent of fi  ndings from   Drosophila  , where CSL mutations can 
produce less severe phenotypes than those of Notch because 
Notch function is not restricted to relief of CSL-mediated 
transcriptional repression (  73  ). Indeed, there are many exam-
ples of CSL-independent Notch functions. Truncated forms 
of Notch that cannot bind CSL retain activity (  74  –  76  ). NICD 
can bind to and enhance the activity of transcription factors 
other than CSL (  72, 74, 76, 77  ). Notch can indirectly modu-
late the transcription of CSL-independent genes via com-
petition for transcriptional coactivators (  78  ), a function that 
remains in tact in   RBPJ        KO cells or dnMAML-expressing 
cells. Additional CSL-independent roles proposed for Notch 
include functions based on its interactions with proteins such 
as Deltex, NF-     B, and the IKK complex (  70, 72, 79  ). 
  As well as promoting transcription of Notch target genes, 
additional functions could explain the phenotypic diff  er-
ences of PS, dnMAML, and CSL mutant mice and      -secretase 
inhibitor  –  treated cultures. Loss of CSL may aff  ect gene silenc-
ing (  26  ) because it is a default repressor, MAML acts as a 
coactivator for several transcription factors (  80, 81  ), and PS 
can regulate proteins other than Notch. The fact that PSs 
have multiple substrates has been a relatively minor concern 
because, with the exception of Notch, thymocytes do not 
express most of the known      -secretase substrates, and the PS 
substrates present in thymocytes show no functional impor-
tance by gene deletion. Moreover, many papers describe 
the use of pharmacological      -secretase inhibitors to prevent 
Notch signaling during thymocyte development, and to date, 
no Notch-independent eff  ects have been reported. To the 
contrary, several lines of evidence support the contention 
from DP thymocytes (Fig. S4, available at http://www.jem
.org/cgi/content/full/jem.20070550/DC1). Despite the dra-
matic phenotype of PS1/2KO thymocytes, few genes were 
diff  erentially expressed greater than twofold. This was con-
sistent with data showing that blocking Notch hyperactivity 
in T-ALL cells results in no more than threefold diff  erences 
in gene expression (  60  ). In agreement with the fl  ow cytometry 
data, PS1/2KO thymocytes showed reduced levels of CD5 
mRNA, whereas mRNA for CD3, CD4, CD8, CD44, and 
CD69 were equivalent. No diff   erences were observed in 
mRNA level for proteins involved in proximal TCR signaling, 
e.g., Lck and ZAP70. Consistent with a failure to detect 
increased apoptosis, the expression of antiapoptotic proteins 
Bcl-2 and -X  L   were equivalent. Because Notch can regulate 
the expression of transcription factors, e.g., c-Myc and c-Fos 
(  60, 61  ), one intriguing diff  erence in PS1/2KO thymocytes 
is the increased expression of AP-1 family members, a change 
that compliments the observation that Notch activity causes 
down-regulation of cFos (  62  ). Altered expression of AP-1 
proteins is notable because they infl  uence cell cycle progres-
sion and diff  erentiation, and extracellular signal-regulated 
  kinase and AP-1 often regulate one another (  63, 64  ). Moreover, 
in mature CD4 T cells, JunB is important in Th2 lineage 
cells, and Th1/2 responses can be altered in the absence of 
Notch (  7, 20, 28, 65  ). 
  Although the most likely explanation for impaired TCR 
signaling in PS1/2KO thymocytes is altered gene expression, 
the possibility that Notch physically participates in TCR sig-
naling cannot be excluded. Notch proteins are expressed by 
DP thymocytes (  32, 66  –  69  ) and can be recruited to the site 
of TCR  –  MHC contact between DP thymocytes and APCs 
(  32  ). Notch can bind PI3 kinase, Lck, and members of the 
ubiquitously expressed Deltex family (  49, 70, 71  ). Because 
Deltex proteins are detected in the cytoplasm and have do-
mains that can interact with both Notch and SH3 domain  –
  containing proteins like Grb2, they have the potential to 
mediate clustering of these proteins at the membrane where 
proximal TCR signaling occurs. Notch has also been shown 
to physically associate with NF- b and the IKK complex, and 
to infl  uence NF- b activity (  30, 72  ). 
  Conditional PS1/2KO mice are the fi  rst Notch loss-of-
function model reported to have defects in TCR signaling 
and MHC selection. Because thymocytes express all four 
Notch homologues, and the NICDs of Notch1  –  3 are highly 
conserved, it is not surprising that loss of any single Notch 
family member has no eff  ect on thymocyte selection (  16  –  19  ). 
It might be expected, however, that mutation of PS, dnMAML, 
and CSL would have similar eff  ects. Nevertheless, no abnor-
malities in DP cellularity or in the development of SP thy-
mocytes were reported with Cd4Cre-mediated RBPJ  gene 
deletion or dnMAML induction (  7  –  20  ). The more severe ef-
fects of PS defi  ciency could refl  ect diff  erences in the model 
systems, such as the half-life of PS, dnMAML, and CSL pro-
teins. Both NICD and MAML are short-lived, but it is un-
clear whether CSL is degraded after Notch activation or if 
CSL remains permanently bound to DNA (  58  ). Another JEM VOL. 204, September 3, 2007 
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and support a model in which PS-dependent Notch activa-
tion infl  uences positive selection and CD4/CD8 T cell de-
velopment by modifying TCR signal strength. Precisely how 
the Notch and TCR pathways work together remains to be 
elucidated. Notch signaling could regulate transcription of 
components of TCR signal transduction and/or directly par-
ticipate in proximal TCR signaling. Similar gaps exist regard-
ing the mechanism by which Notch functions at other stages 
of lymphocyte development. For example, even though it is 
known that Notch signaling is required for commitment to 
the T cell lineage, transition from the DN to DP stage, and 
generation of marginal zone B cells, we still lack a detailed 
understanding of what genes are induced/repressed, what cell 
types receive the Notch signal, and in what cell types/tissues 
fate decisions are made. It is also largely unknown what fac-
tors regulate the pattern of gene expression that underlies se-
lection at the DP stage. Even in TCR           transgenic mice 
where all DP thymocytes express the same TCR, only a sub-
set become SP, indicating that factors other than TCR/MHC 
affi   nity play a critical role in determining which DP cells are 
positively selected. Given our observations, the expression 
patterns of PS, Notch1  –  4, and Notch ligands in the thymus, 
and the well-established role of Notch in infl  uencing cell fate 
decisions; indeed, Notch could be regulating the genes that 
ultimately determine DP thymocyte selection. The future chal-
lenge will be to further dissect the complex interactions be-
tween Notch and other signaling pathways that allow Notch 
to exert lineage- and stage-specifi  c eff  ects across a broad range 
of cell types. 
    MATERIALS AND METHODS   
  Mice.     Floxed (f/f)   PS1   (  37  ) mutant and   PS2-  null mutant (  35  ) mice have 
been previously described and were provided by R. Feng and J. Tsien 
(Princeton University, Princeton, NJ) and A. Bernstein and D. Donoviel 
(Mount Sinai Hospital, Toronto, Canada), respectively.   PS1  -null mutant 
mice were provided by S. Sisodia and P. Wong (Johns Hopkins University, 
Baltimore, MD) (  84  ). pLck-Notch1IC9 transgenic mice were provided by 
E. Robey (University of California, Berkeley, Berkeley, CA) (  14  ). huCd2-Cd5 
transgenic mice were created and provided by P. Love (National Institute 
of Child Health and Human Development, National Institutes of Health, 
Bethesda, MD) (  43  ).   Cd5  -null mutant mice (  41  ) were created by Klaus 
  Rajewsky and provided by Paul Love. Floxed   RBPJ    mutant mice were 
  produced by T. Honjo (  85  ) and provided by L. Hennighausen (National 
  Institute of Diabetes and Digestive and Kidney Diseases, National Institutes 
of Health, Bethesda, MD). H-2  b   C57BL/10 (B10)   Rag2   and B6.SJL-Cd45  a   
  Rag1  -null mutants, B6.SJL-Cd45  a   (also called Ptprc  a   or Ly5  a  ), transgenic B6 
Cd4Cre and B10 or B10.A (H-2  k  ) AND TCR, 5CC7 TCR, and F5 TCR 
mice were obtained from a National Institute of Allergy and Infectious 
Disease (NIAID) breeding contract with Taconic. All TCR transgenic mice 
used for this study were RAG defi  cient, so no endogenous TCRs were ex-
pressed. MHC-defi  cient (B6   A  b   / 2M  -null mutant) mice were purchased 
from Taconic. Mice were bred and maintained under specifi  c pathogen-free 
conditions in the NIAID Research Animal Facilities in accordance with 
American Association of Laboratory Animal Care specifi  cations, and on pro-
tocols approved by the NIAID Animal Care and Use Committee. 
  Hematopoietic chimeras.     BM suspensions were depleted of mature 
T cells with antibodies to Thy1.2 (J1J) and CD5 (C3PO), plus low-toxicity 
rabbit complement (Cedarlane Laboratories). Mixed hematopoietic chime-
ras were made by reconstitution of sublethally irradiated RAG2-defi  cient 
recipients (500 rad, cesium source). H-2  b   PS2 KO (  Cd45      b  ; the control for 
that inhibition of Notch signaling is responsible for the phe-
notypes of PS1/2KO thymocytes reported here. Importantly, 
both the DN to DP block and TCR signaling defects can be 
corrected by introduction of NICD. Reciprocal to PS defi  -
ciency, wild-type DP thymocytes expressing a NICD Tg 
show enhanced TCR signal transduction (  24, 33, 51  ). The 
phenotype of Tg NICD DP thymocytes suggests that posi-
tive selection and TCR signaling are improved in vivo. In 
vitro NICD Tg DP cells respond as well or better than wild-
type thymocytes to TCR stimulation. 
  Although reciprocal results are observed for PS1/2KO 
and NICD Tg mice in respect to signaling in DP thymo-
cytes, these mutations do not yield reciprocal results in re-
spect to CD4/CD8 SP thymocyte development. Paradoxically, 
both show reduced development of CD4 SP cells. However, 
positive selection and SP generation is a complex, multistep 
process whereby the net TCR signal achieved by a DP 
thymocyte undergoing selection is determined by many factors, 
including TCR/MHC affi   nity, thymocyte  –  stromal cell ad-
hesion, and thymocyte migration. Because Notch is a master 
regulator of gene expression, constitutive overexpression of 
NICD likely induces many changes not mediated by endog-
enous Notch. 
  At this time, we have no evidence that inhibiting endog-
enous Notch signaling by eliminating PS has any impact 
on CD4/CD8 lineage commitment. Aside from attenuating 
TCR signaling in DP and reducing SP thymocyte genera-
tion, CD4/CD8 lineage specifi  cation appears normal in con-
ditional PS1/2KO mice. In addition to the TCR Tg data 
shown, selection of the diverse TCR repertoire shows nor-
mal MHC class I and class II dependence for CD8 and CD4 
SP development, respectively (unpublished data). Although 
Notch is widely acknowledged for a direct role in binary cell 
fate decisions, our data suggest that PS eff  ects on CD4/CD8 
T cell fate are mediated through the ability of Notch activity 
to modulate TCR signaling. We propose that the quantity of 
TCR signaling is the primary CD4/CD8 cell fate determi-
nant, whereas PS-dependent activation of Notch serves to 
modulate TCR signals and, in doing so, aff  ects the outcome 
of positive selection. These fi  ndings are reminiscent of those 
from vulva development in   Caenorhabditis elegans  , where Notch 
reinforces a fate decision initially biased by the quantity of 
the epidermal growth factor  –  mitogen-activated kinase signal 
by creating a negative-feedback loop that accentuates small 
diff  erences in signaling (  82  ). The Notch and Ras signaling 
pathways also collaborate in   Drosophila   photoreceptor R7 
specifi  cation (  83  ), where Notch signals create a positive-
feedback loop, leading to a stronger, more sustained Ras sig-
nal. In these examples, Notch reinforces a signaling pathway 
that is actually the primary determinant of cell fate. In an 
analogous way, PS-dependent Notch signaling may reinforce 
TCR signaling in thymocytes to infl  uence positive selection, 
and in peripheral T cells, TCR and Notch signals may cooperate 
to determine Th1/2 lineage choice. 
  Collectively, our studies provide in vivo evidence that 
TCR and Notch signaling pathways are functionally linked, 2126 TCR AND NOTCH SIGNALING IN          T CELL DEVELOPMENT | Laky and Fowlkes
anti    –CD5-FITC and -PE(53  –  7.3); anti  –  CD4-CyC (RM4-5); anti  –  CD8     -CyC 
(53  –  6.7); anti  –  CD11c-PE (HL3); anti  –  CD19-PE (1D3); anti  –  CD25-FITC 
(7D4); anti  –  CD44-Biotin (IM7); anti  –  CD45-FITC (30-F11); anti  –  CD45.1-
PE (A20); anti  –  CD45R-CyC (RA3-6B2); anti  –  CD49b-PE(DX5); anti  –
  CD69-FITC (H1.2F3); anti  –  TCR           PE (GL3); anti  –  TCR          -FITC, -APC 
(H57.597), and -TCRV     11 (RR8-1); anti  –  NK1.1-PE (PK136); anti  –  Ter119-
PE (TER-119); anti  –  I-A  b  -PE(AF6-120.1); anti  –  I-A/I-E-PE (M5/114.15.2); 
anti  –  BrdU-FITC, and -APC (3D4). The following were obtained from Cal-
tag Laboratories: anti  –  CD8     -FITC, -PE (CT-CD8), and anti  –  CD45R-PE 
(RA3-6B2). The following were purchased from eBioscience: anti-CD11b-
PE (M1/70); anti-CD44-APC (IM7); anti-CD45.2-FITC, -PE, -PE-Cy5.5, 
and -APC-Cy5.5 (104); anti-CD45.1-FITC, -PE-Cy5.5, and -APC (A20); 
anti-CD122-PE (5H4); anti-F4/80-PE (BM8); anti-TCR          -PE (H57.597); 
anti-Ly6G (GR1)-PE (RB6-8C5). The following was obtained from Becton 
Dickinson Collaborative Technologies: anti-CD4-PE (GK1.5). Biotin-conjugated 
antibodies were visualized with Streptavidin-PE and -Cy5 (Jackson Immuno-
Research Laboratories). 
  Immunofl  uorescence analysis.     A single-cell suspension of lymphocytes 
in HBSS containing 0.2% BSA and 0.1% NaN  3   (HBSS/BSA/NaN  3  ) was in-
cubated with properly diluted mAb at 4  °  C for 20 min. After staining, cells 
were washed twice with PBS/BSA/NaN  3  , and relative fl  uorescence intensi-
ties were measured by four-color fl  uorescence fl  ow cytometry using a FACS-
Calibur fl  ow cytometer with CellQuest software (both from Becton Dickinson), 
and FlowJo software (Tree Star, Inc.) was used for analysis. Staining for in-
corporated BrdU was performed using a BrdU Flow kit (BD Biosciences) 
according to the manufacturer  ’  s instructions. 
  Ca  2+   measurements.     Thymocytes were washed and resuspended in HBSS 
with calcium and magnesium, 10 mM Hepes, and 1% FBS and probenecid. 
The calcium probe Indo-1 and detergent the Pluronic (Invitrogen) were added 
to cells and incubated for 30 min at 37  °  C. After washing, the cells were 
stained at room temperature with anti-CD8, -CD4, and -TCR. Cells were 
analyzed on an LSR II fl  ow cytometer (Becton Dickinson) equipped with an 
argon laser tuned to 488 nm, a HeNe laser tuned to 633 nm, and a He-Cd UV 
laser tuned to 325 nm. Indo-1 fl  uorescence was analyzed using a 450-DC-LP 
dichroic beam splitter and emission fi  lters at 395/20 and 530/30 nm for bound 
and free probes, respectively. The signals for bound and unbound Indo-1 were 
collected in linear mode. For each stimulation, an aliquot of cells in HBSS 
with 2 mM Ca (Biosource) was warmed at 37  °  C for 5 min before stimulation 
with azide-free, low-endotoxin, biotinylated anti-CD3 (2C11). Data were 
collected for 30 s, at which time 10      g/ml Streptavidin (Sigma-Aldrich) was 
added. In some cases, 8      g/ml ionomycin (Calbiochem) was added. To measure 
internal Ca  2+   stores, cells were suspended in Ca  2+  -free HBSS with 0.5 mM 
EGTA; 10      g/ml thapsigargin (Sigma-Aldrich) was added at 30 s, and data 
were collected for an additional 9.5 min. FACSDiva (Becton Dickinson) 
software was used for data acquisition, and FlowJo software (Tree Star, Inc.) 
was used for kinetic analysis. 
  Statistical analyses.     All two-tailed Student  ’  s   t   tests and linear regression 
analyses were conducted using Excel. Statistical analysis of BrdU labeling 
data were analyzed using Prism version 4.03 (GraphPad) for Windows. Error 
bars represent the SEM, where   n         9 individual mice. 
  Online supplemental material.     Fig. S1 shows PS2 expression by thymocytes. 
Fig. S2 shows the eff  ect of PS defi  ciency on MHC class II  –  restricted 5CC7 
TCR Tg thymocytes. Fig. S3 shows the eff  ect of PS defi  ciency on MHC class I  –
  restricted F5 TCR Tg thymocytes. Fig. S4 shows changes in gene expression in 
control versus PS1/2  °   DP thymocytes. Fig. S5 shows timing of CD4Cre-
mediated gene deletion in RBPJ       fl  ox   thymocytes. The online version of this 
article is available at http://www.jem.org/cgi/content/full/jem.20070550/DC1. 
  We appreciate the expert technical assistance of Sharron Evans, Rebecca Amos, 
and David Stephany. We thank Ellen Robey, Wendy Shores, Paul Love, and Nevil Singh 
for helpful discussion and comments on the manuscript. 
the PS1/2KO) and B6.SJL (  Cd45  a    ) BM cells were mixed at a ratio of 1:1; 
H-2  b   PS1/2KO (  Cd45  b    ) and B6.SJL (  Cd45  a    ) BM cells were mixed at a ratio 
of 10:1. To study thymocyte development in the absence of selection, le-
thally irradiated MHC-defi  cient recipients (1,000 rad, cesium source) were 
reconstituted with T cell  –  depleted BM cells. Irradiated mice were main-
tained on antibiotic water until analysis at 4  –  6 wk after reconstitution. 
  Lymphocyte isolation.     Thymocyte single-cell suspensions were generated 
using 100      m nylon mesh (PGC Scientifi  cs). 
  PCR.     Genotyping for the fl  oxed   PS1   allele was performed using prim-
ers and PCR conditions previously described (  37  ). The deleted   PS1   allele 
was detected with an additional primer, 5     -GCATATGAATACCATG-
TAGCTG-3     . To detect the 533-bp PCR product generated by the de-
leted   PS1   allele, samples were amplifi  ed for an additional 10 cycles, for 
a total of 45 cycles. The fl  oxed and deleted   RBPJk   alleles were detected 
using the following three primers: 5     -GATAGACCTTGGTTTGTT-
GTTTGG-3     , 5     -CCACTGTTGTGAACTGGCGTGG-3     , and 5     -AA-
CATCCACAGCAGGCAAC-3     . PCR amplifi  cation of   RBPJk   fl  oxed     allele 
yields a PCR product of     500 bp, and the deleted   RBPJk   allele yields a 
product of     700 bp. Lineage-negative thymocytes were enriched by mag-
netic bead depletion using a lineage cocktail containing phycoerythrin (PE)-
conjugated antibodies recognizing CD3     , CD4, CD8     , CD11b, CD11c, 
CD19, CD45R, CD49b, CD122, Ter119, I-A, I-E, F4/80, Ly6G, TCR          , 
TCR          , and NK1.1 plus anti-PE beads and an AutoMACS (Miltenyi Biotec). 
Individual subsets of Lin  −   thymocytes were obtained by cell sorting for 
Lin  −  CD45+CD44+CD25+ (DN2), Lin  −  CD45+CD44  −  CD25+ (DN3), 
and Lin  −  CD45+CD44  −  CD25  −   (DN4) subsets. DP and SP thymocytes 
were isolated by cell sorting CD4+CD8+ (DP), TCR       hi  CD4+ (CD4 SP), 
and TCR       hi  CD8+ (CD8 SP). 
  RT-PCR.     RNA was isolated using Trizol (Invitrogen) according to the 
manufacturer  ’  s instructions. cDNA was generated using a SuperScript III 
First-strand Synthesis System for RT-PCR kit (Invitrogen) according to 
manufacturer  ’  s instructions. The primers used were Hes1 forward 5     -GC-
CAGTGTCAACACGACACCG-3     , Hes1 reverse 5    -TCACCTCGTTCA 
  TGCACTCG-3     ,      -actin forward 5     -GTGGGCCGCTCTAGGCACCAA-3     , 
and      -actin reverse 5     - CTCTTTGATGTCACGCACGATTTC-3     . 
  Protein lysates and Western blotting.     Single-cell suspensions were lysed 
in buff  er containing 20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% 
NP-40, 1 mM Na  3  VO  4  , and protease inhibitor tablets (Roche). Samples 
were incubated on ice for  30 min, inverted every 10 min to mix, and spun 
for 5 min at 12,000 rpm at 4 C. Supernatants were stored at   −  80 C. 
  Lysates were subjected to PAGE (Novex 12% NuPAGE gels) with MES 
buff  er (Invitrogen), and transferred to Hybond-P polyvinylidene difl  uoride 
membranes (GE Healthcare). After blocking with 5% nonfat dried milk in 
PBS/0.01% Tween 20, blots were hybridized overnight at 4 C with antisera in 
PBS/0.01% Tween20 with 2.5% nonfat dried milk. Antibodies used were anti-
PS1 (303  –  316; Oncogene Research Products/Calbiochem), anti  –   -tubulin 
(H-235; Santa Cruz Biotechnology) and secondary anti  –  mouse-IgG-POD/
anti  –  rabbit IgG-POD (Roche). Blots were developed with ECL Western 
Blotting Analysis System (GE Healthcare) or SuperSignal West Dura Ex-
tended Duration Substrate (Pierce Chemical Co.). 
  In vivo BrdU labeling.     Each mouse received a single i.p. injection with 
1.8 mg BrdU (BD Biosciences) and was then maintained on drinking water 
supplemented with 0.8 mg/ml BrdU (Sigma-Aldrich) for up to 7 d. Data 
points for BrdU  CD4 CD8  DP or TCR  hi   CD4 and CD8 SP thymocytes 
are shown as a percentage of total thymocytes plotted against labeling time. 
Slopes of the lines were calculated using the linear curve function with a 
spreadsheet program (Excel; Microsoft). For DP thymocytes, only data points 
in the linear part of the curve (day 0  –  3) were used to calculate slopes. 
  Monoclonal antibodies.     The following monoclonal antibodies were pur-
chesed from BD Biosience: anti-CD3 -PE, -CyC, and -APC (145-2C11); JEM VOL. 204, September 3, 2007 
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